Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics
Current Oncology · 14.04.2024 · 31 (4) · 2233-2243
DOI: 10.3390/curroncol31040165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 14.04.2024. Verfasst von Effrosyni I Styliara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece. Hauptthemen laut MEDLINE: Glioblastoma, Magnetic Resonance Imaging, Brain Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Extracting multiregional radiomic features from multiparametric MRI for predicting pretreatment survival in isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM) patients is a promising approach.
Methods
MRI data from 49 IDH wild-type glioblastoma patients pre-treatment were utilized. Diffusion and perfusion maps were generated, and tumor subregions segmented. Radiomic features were extracted for each tissue type and map. Feature selection on 1862 radiomic features identified 25 significant features. The Cox proportional-hazards model with LASSO regularization was used to perform survival analysis. Internal and external validation used a 38-patient training cohort and an 11-patient validation cohort. Statistical significance was set at p < 0.05.
Results
Age and six radiomic features (shape and first and second order) from T1W, diffusion, and perfusion maps contributed to the final model. Findings suggest that a small necrotic subregion, inhomogeneous vascularization in the solid non-enhancing subregion, and edema-related tissue damage in the enhancing and edema subregions are linked to poor survival. The model’s C-Index was 0.66 (95% C.I. 0.54–0.80). External validation demonstrated good accuracy (AUC > 0.65) at all time points.
Conclusions
Radiomics analysis, utilizing segmented perfusion and diffusion maps, provide predictive indicators of survival in IDH wild-type glioblastoma patients, revealing associations with microstructural and vascular heterogeneity in the tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
- Medical Physics Lab, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
- Department of Neurosurgery, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
ORCID-Profile: Effrosyni I Styliara, Loukas G Astrakas, George Alexiou
Zitieren
APA
Styliara, E. I., Astrakas, L. G., Alexiou, G., Xydis, V. G., Zikou, A., Kafritsas, G., Voulgaris, S., & Argyropoulou, M. I. (2024). Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics. Current Oncology, 31(4), 2233-2243. https://doi.org/10.3390/curroncol31040165
Vancouver
Styliara EI, Astrakas LG, Alexiou G, Xydis VG, Zikou A, Kafritsas G, et al. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics. Current Oncology. 2024;31(4):2233-2243. doi:10.3390/curroncol31040165
BibTeX
@article{Styliara2024,
author = {Styliara, Effrosyni I and Astrakas, Loukas G and Alexiou, George and Xydis, Vasileios G and Zikou, Anastasia and Kafritsas, Georgios and Voulgaris, Spyridon and Argyropoulou, Maria I},
title = {Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics},
journal = {Current Oncology},
year = {2024},
volume = {31},
number = {4},
pages = {2233--2243},
doi = {10.3390/curroncol31040165}
}
EUVIMED